IGF::OT::IGF INITIAL ADMINISTRATIVE CHARGES TO#1 PRE-CLIN TOX STUDY OF DRUG DEV FOR CANCER PATIENTS HHSN261201600017I DTP-16-043 TPB
$1,500N03FY2016CANIH
Sri International, Menlo Park CA
Investigators
Abstract
Start-Up Toxicology Meeting
View original record on NIH RePORTER →